FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer

Expanded indication makes cobas HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV Test for use as a first-line primary screening test for cervical cancer in women 25 and older.

http://ift.tt/1lN8uE6